Genprex, a clinical-stage gene therapy company, has recently released groundbreaking data from a non-human primate study evaluating a novel gene therapy to treat Type 1 diabetes. This therapy is part of Genprex's mission to develop life-changing therapies for patients with cancer and diabetes who currently have limited treatment options.